Stay updated on Pembrolizumab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedThe footer’s site revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check13 days agoChange DetectedThe ClinicalTrials.gov site revision label in the footer changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedA new revision entry (v3.7.0) was added to the study record history, and the previous revision (v3.6.6) was removed. This reflects an update to the version history rather than changes to study data or descriptions.SummaryDifference0.0%

- Check55 days agoChange DetectedThe history page now shows Revision: v3.6.6 instead of v3.6.5, representing a small site update and not a change to the study record content.SummaryDifference0.0%

- Check76 days agoChange DetectedThe footer now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a version update of the site rather than changes to the study history data.SummaryDifference0.0%

- Check90 days agoChange DetectedRevision metadata on the page updated from v3.6.3 to v3.6.4, signaling a new site revision is now in effect. The change reflects a backend/UI version update rather than a modification to the study history content.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Solid Tumors Clinical Trial page.